MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gain (loss) on
marketable securities, net...
$695K
(392.02%↑ Y/Y)
Total comprehensive
(loss) income
-$143,055K
(-318.78%↓ Y/Y)
Total other
comprehensive income (loss)
$695K
(392.02%↑ Y/Y)
Net (loss) income
-$143,750K
(-319.04%↓ Y/Y)
Interest and other income
$15,072K
(-22.60%↓ Y/Y)
(loss) income before
provision for income taxes
-$142,800K
(-314.79%↓ Y/Y)
Total income tax
provision
$924K
(7.57%↑ Y/Y)
Total other income
$15,072K
(-22.60%↓ Y/Y)
(loss) income from
operations
-$157,898K
(-435.87%↓ Y/Y)
Collaboration revenue
$25,421K
(-87.94%↓ Y/Y)
Total operating
expenses
$183,319K
(11.94%↑ Y/Y)
Research and development
$142,269K
(13.54%↑ Y/Y)
General and
administrative
$41,050K
(6.72%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics, Inc. (TRDA)